The Foreign Body Response: At the Interface of Surgery and Bioengineering

Plastic and Reconstructive Surgery

Volumn 135, Issue 5, 2015, Pages 1489-1498

  Major, Melanie R ^a   Wong, Victor W ^a   Nelson, Emily R ^a   Longaker, Michael T ^a   Gurtner, Geoffrey C ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ADVERSE EFFECTS; BIOENGINEERING; FOREIGN-BODY REACTION; HUMAN; PLASTIC SURGERY; PROSTHESES AND ORTHOSES; STANDARDS;

BIOCOMPATIBLE MATERIALS; BIOENGINEERING; FOREIGN-BODY REACTION; HUMANS; PROSTHESES AND IMPLANTS; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 84936078346     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000001193     Document Type: Article

References (73)

1. Arujuna A, Williams S, Whittaker J, et al. Trends, indications and outcomes of cardiac implantable device system extraction: A single UK centre experience over the last decade. Int J Clin Pract. 2012;66:218-225.
2. MarketResearch.com. Biomaterials: A global market overview. Industry experts market report, 2011. Available at: http://www. marketresearch.com/Industry-Experts-v3766/Biomaterials-Global-Overview-6274073/. Accessed April 6, 2014.
3. Williams DF. On the nature of biomaterials. Biomaterials 2009;30:5897-5909.
4. Bryers JD, Giachelli CM, Ratner BD. Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts. Biotechnol Bioeng. 2012;109:1898-1911.
5. Hwang K, Sim HB, Huan F, Kim DJ. Myofibroblasts and capsular tissue tension in breast capsular contracture. Aesthetic Plast Surg. 2010;34:716-721.
6. Rennert RC, Rustad K, Levi K, et al. A histological and mechanical analysis of the cardiac lead-tissue interface: Implications for lead extraction. Acta Biomater. 2014;10:2200-2208.
7. Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008;60:184-198.
8. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86-100.
9. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178:2147-2156.
10. Kvist PH, Iburg T, Bielecki M, et al. Biocompatibility of electrochemical glucose sensors implanted in the subcutis of pigs. Diabetes Technol Ther. 2006;8:463-475.
11. Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest. 1996;97:1329-1334.
12. Hu WJ, Eaton JW, Ugarova TP, Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001;98:1231-1238.
13. Zaveri TD, Lewis JS, Dolgova NV, Clare-Salzler MJ, Keselowsky BG. Integrin-directed modulation of macrophage responses to biomaterials. Biomaterials 2014;35:3504-3515.
14. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697-715.
15. Galli SJ, Borregaard N, Wynn TA. Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat Immunol. 2011;12:1035-1044.
16. Ma J, Chen T, Mandelin J, et al. Regulation of macrophage activation. Cell Mol Life Sci. 2003;60:2334-2346.
17. Brown BN, Ratner BD, Goodman SB, Amar S, Badylak SF. Macrophage polarization: An opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials 2012;33:3792-3802.
18. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression. J Immunol. 2006;177:7303-7311.
19. Sussman EM, Halpin MC, Muster J, Moon RT, Ratner BD. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction. Ann Biomed Eng. 2013;14:1508-1516.
20. Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008;14:1835-1842.
21. Spiller KL, Anfang RR, Spiller KJ, et al. The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 2014;35:4477-4488.
22. Anderson JM. Multinucleated giant cells. Curr Opin Hematol. 2000;7:40-47.
23. Wiggins MJ, Wilkoff B, Anderson JM, Hiltner A. Biodegradation of polyether polyurethane inner insulation in bipolar pacemaker leads. J Biomed Mater Res. 2001;58:302-307.
24. Hernandez-Pando R, Bornstein QL, Aguilar Leon D, Orozco EH, Madrigal VK, Martinez Cordero E. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells. Immunology 2000;100:352-358.
25. McNally AK, Jones JA, Macewan SR, Colton E, Anderson JM. Vitronectin is a critical protein adhesion substrate for IL-4-induced foreign body giant cell formation. J Biomed Mater Res A 2008;86:535-543.
26. Moreno JL, Mikhailenko I, Tondravi MM, Keegan AD. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: Contribution of E-cadherin. J Leukoc Biol. 2007;82:1542-1553.
27. Jay SM, Skokos E, Laiwalla F, Krady MM, Kyriakides TR. Foreign body giant cell formation is preceded by lamellipodia formation and can be attenuated by inhibition of Rac1 activation. Am J Pathol. 2007;171:632-640.
28. Helming L, Tomasello E, Kyriakides TR, et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci Signal. 2008;1:ra11.
29. Kyriakides TR, Foster MJ, Keeney GE, et al. The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation. Am J Pathol. 2004;165:2157-2166.
30. Jones JA, McNally AK, Chang DT, et al. Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 2008;84:158-166.
31. Le NT, Xue M, Castelnoble LA, Jackson CJ. The dual personalities of matrix metalloproteinases in inflammation. Front Biosci. 2007;12:1475-1487.
32. MacLauchlan S, Skokos EA, Meznarich N, et al. Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. J Leukoc Biol. 2009;85:617-626.
33. Junge K, Binnebösel M, von Trotha KT, et al. Mesh biocompatibility: Effects of cellular inflammation and tissue remodelling. Langenbecks Arch Surg. 2012;397:255-270.
34. Binnebösel M, von Trotha KT, Ricken C, et al. Gentamicin supplemented polyvinylidenfluoride mesh materials enhance tissue integration due to a transcriptionally reduced MMP-2 protein expression. BMC Surg. 2012;12:1.
35. Steiert AE, Boyce M, Sorg H. Capsular contracture by silicone breast implants: Possible causes, biocompatibility, and prophylactic strategies. Med Devices (Auckl.) 2013;6:211-218.
36. Berry MG, Cucchiara V, Davies DM. Breast augmentation: Part II. Adverse capsular contracture. J Plast Reconstr Aesthet Surg. 2010;63:2098-2107.
37. Barnsley GP, Sigurdson LJ, Barnsley SE. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: A meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2006;117:2182-2190.
38. Prasad BR, Brook MA, Smith T, et al. Controlling cellular activity by manipulating silicone surface roughness. Colloids Surf B Biointerfaces 2010;78:237-242.
39. Pajkos A, Deva AK, Vickery K, Cope C, Chang L, Cossart YE. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111:1605-1611.
40. Rieger UM, Mesina J, Kalbermatten DF, et al. Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg. 2013;100:768-774.
41. Schreml S, Heine N, Eisenmann-Klein M, Prantl L. Bacterial colonization is of major relevance for high-grade capsular contracture after augmentation mammaplasty. Ann Plast Surg. 2007;59:126-130.
42. Ibrahim AM, Ayeni OA, Hughes KB, Lee BT, Slavin SA, Lin SJ. Acellular dermal matrices in breast surgery: A comprehensive review. Ann Plast Surg. 2013;70:732-738.
43. Cheng A, Lakhiani C, Saint-Cyr M. Treatment of capsular contracture using complete implant coverage by acellular dermal matrix: A novel technique. Plast Reconstr Surg. 2013;132:519-529.
44. Holton LH III, Chung T, Silverman RP, et al. Comparison of acellular dermal matrix and synthetic mesh for lateral chest wall reconstruction in a rabbit model. Plast Reconstr Surg. 2007;119:1238-1246.
45. Beale EW, Hoxworth RE, Livingston EH, Trussler AP. The role of biologic mesh in abdominal wall reconstruction: A systematic review of the current literature. Am J Surg. 2012;204:510-517.
46. Janis JE, O'Neill AC, Ahmad J, Zhong T, Hofer SO. Acellular dermal matrices in abdominal wall reconstruction: A systematic review of the current evidence. Plast Reconstr Surg. 2012;130(Suppl 2):183S-193S.
47. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33(Suppl 2):S168-S175.
48. Sanchis-Bielsa JM, Bagán JV, Poveda R, Salvador I. Foreign body granulomatous reactions to cosmetic fillers: A clinical study of 15 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:237-241.
49. Wollina U, Goldman A. Dermal fillers: Facts and controversies. Clin Dermatol. 2013;31:731-736.
50. McLaughlin JK, Lipworth L, Murphy DK, Walker PS. The safety of silicone gel-filled breast implants: A review of the epidemiologic evidence. Ann Plast Surg. 2007;59:569-580.
51. Rubin JP, Yaremchuk MJ. Complications and toxicities of implantable biomaterials used in facial reconstructive and aesthetic surgery: A comprehensive review of the literature. Plast Reconstr Surg. 1997;100:1336-1353.
52. Bota PC, Collie AM, Puolakkainen P, et al. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res A 2010;95:649-657.
53. Otto J, Binnebösel M, Pietsch S, et al. Large-pore PDS mesh compared to small-pore PG mesh. J Invest Surg. 2010;23:190-196.
54. Roach P, Eglin D, Rohde K, Perry CC. Modern biomaterials: A review. Bulk properties and implications of surface modifications. J Mater Sci Mater Med. 2007;18:1263-1277.
55. Tan HC, Poh CK, Cai Y, Wang W. Anti-fibrosis effect of BMP-7 peptide functionalization on cobalt chromium alloy. J Orthop Res. 2013;31:983-990.
56. Petrie TA, Raynor JE, Dumbauld DW, et al. Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci Transl Med. 2010;2:45ra60.
57. Jiang S, Cao Z. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv Mater. 2010;22:920-932.
58. MacEwan MR, Brodbeck WG, Matsuda T, Anderson JM. Monocyte/lymphocyte interactions and the foreign body response: In vitro effects of biomaterial surface chemistry. J Biomed Mater Res. 2005;74:285-293.
59. Harding JL, Reynolds MM. Combating medical device fouling. Trends Biotechnol. 2014;32:140-146.
60. Khandwekar A, Rho CK. Modulation of cellular responses on engineered polyurethane implants. J Biomed Mater Res A 2012;100:2211-2222.
61. Schaer TP, Stewart S, Hsu BB, Klibanov AM. Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. Biomaterials 2012;33:1245-1254.
62. Morais JM, Papadimitrakopoulos F, Burgess DJ. Biomaterials/tissue interactions: Possible solutions to overcome foreign body response. AAPS J. 2010;12:188-196.
63. Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ. PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation. Int J Pharm. 2010;384:78-86.
64. Zeplin PH, Larena-Avellaneda A, Schmidt K. Surface modification of silicone breast implants by binding the antifibrotic drug halofuginone reduces capsular fibrosis. Plast Reconstr Surg. 2010;126:266-274.
65. Zeplin PH, Larena-Avellaneda A, Jordan M, Laske M, Schmidt K. Phosphorylcholine-coated silicone implants: Effect on inflammatory response and fibrous capsule formation. Ann Plast Surg. 2010;65:560-564.
66. Vieira VJ, d'Acampora AJ, Marcos AB, et al. Vascular endothelial growth factor overexpression positively modulates the characteristics of periprosthetic tissue of polyurethanecoated silicone breast implant in rats. Plast Reconstr Surg. 2010;126:1899-1910.
67. Boehler R, Kuo R, Shin S, et al. Lentivirus delivery of IL-10 to promote and sustain macrophage polarization towards an anti-inflammatory phenotype. Biotechnol Bioeng. 2014;111:1210-1221.
68. Bédard EL, Kim P, Jiang J, et al. Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 2003;76:249-252.
69. Boomker JM, Luttikhuizen DT, Veninga H, et al. The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7. Biomaterials 2005;26:4874-4881.
70. Ulrich D, Edwards SL, Su K, et al. Human endometrial mesenchymal stem cells modulate the tissue response and mechanical behavior of polyamide mesh implants for pelvic organ prolapse repair. Tissue Eng Part A 2014;20:785-798.
71. Kim EH, Heo CY. Current applications of adipose-derived stem cells and their future perspectives. World J Stem Cells 2014;6:65-68.
72. Prichard HL, Reichert W, Klitzman B. IFATS collection: Adipose-derived stromal cells improve the foreign body response. Stem Cells 2008;26:2691-2695.
73. Gao Y, Liu LJ, Blatnik JA, et al. Methodology of fibroblast and mesenchymal stem cell coating of surgical meshes: A pilot analysis. J Biomed Mater Res B Appl Biomater. 2014;102:797-805.